Sinovac Biotech Ltd (SVA) — 6-K Filings

6-K Filings (24)

• Sinovac Biotech Ltd. Files December 2025 6-K Report — Dec 17, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on January 30, 2026, reporting for the month of December 2025. The filing indicates the company's principal executive offi
• Sinovac Biotech Ltd. Files 6-K Report — Nov 20, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on November 20, 2025, for the month of November 2025. The report is for a foreign private issuer and indicates the company
• Sinovac Biotech Ltd. Files November 2025 6-K Report — Nov 5, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on November 5, 2025, reporting for the month of November 2025. The company, headquartered in Beijing, China, is a pharmace
• Sinovac Biotech Ltd. Board Approves Matters in August 2025 Filing — Aug 21, 2025 Risk: low
  Sinovac Biotech Ltd. announced on August 19, 2025, that its Board of Directors approved certain matters. The company, a biopharmaceutical provider in China, fil
• Sinovac Biotech Ltd. Files Form 6-K — Jul 11, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on July 11, 2025, reporting for the month of July 2025. The filing includes a press release as Exhibit 99.1. The company's
• Sinovac Biotech Ltd. Files Form 6-K — Jul 10, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on July 10, 2025, reporting for the month of July 2025. The filing was signed by Dr. Chiang Li, Chairman of the Board, ind
• Sinovac Biotech Files July 2025 6-K Report — Jul 8, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on July 8, 2025, reporting for the month of July 2025. The filing includes an Exhibit 99.1, but the specific content of th
• Sinovac Biotech Ltd. Files July 2025 6-K Report — Jul 2, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on July 2, 2025, for the month of July 2025. The filing indicates that Dr. Chiang Li, Chairman of the Board, has signed on
• Sinovac Biotech Ltd. Files June 2025 6-K Report — Jun 30, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on June 30, 2025, for the month of June 2025. The filing is a report of a foreign private issuer and indicates that the co
• Sinovac Biotech Ltd. Files June 2025 6-K Report — Jun 25, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on June 25, 2025, reporting for the month of June 2025. The filing indicates the company's principal executive offices are
• Sinovac Biotech Files Routine 6-K Report — Jun 20, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on June 20, 2025, for the month of June 2025. The filing was signed by Dr. Chiang Li, Chairman of the Board, indicating th
• Sinovac Biotech Files June 2025 Report — Jun 18, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on June 18, 2025, to report its activities for the month of June 2025. The filing includes a signature from Dr. Chiang Li,
• Sinovac Biotech Ltd. Files May 2025 6-K Report — May 23, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on May 23, 2025, to report its activities for the month of May 2025. The filing indicates the company's principal executiv
• Sinovac Biotech Ltd. Calls Special Shareholder Meeting — May 20, 2025 Risk: low
  Sinovac Biotech Ltd. announced on May 19, 2025, that it disseminated a notice for a special meeting of its shareholders. Shareholders of record as of May 19, 20
• Sinovac Biotech Director Resigns — May 19, 2025 Risk: low
  On May 16, 2025, Sinovac Biotech Ltd. announced the resignation of Mr. Pengfei Li from its board of directors, effective immediately. Mr. Li's departure does no
• Sinovac Biotech Ltd. Files April 2025 6-K Report — Apr 30, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on April 30, 2025, for the month of April 2025. The filing is a report of a foreign private issuer and indicates that the
• Sinovac Biotech Accountant Resigns, Opinions Unreliable — Apr 21, 2025 Risk: high
  On April 15, 2025, Sinovac Biotech Ltd. received notification from Grant Thornton Zhitong Certified Public Accountants LLP that they are resigning as the Compan
• Sinovac Biotech Ltd. Files April 2025 6-K Report — Apr 1, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on April 1, 2025, reporting for the month of April 2025. The filing is a report of a foreign private issuer and includes a
• Sinovac Biotech Ltd. Files March 2025 6-K Report — Mar 31, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on March 31, 2025, reporting for the month of March 2025. The filing includes a press release as Exhibit 99.1. The company
• Sinovac Biotech Files February 2025 Report — Feb 28, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on February 28, 2025, to report its activities for the month of February 2025. The filing includes a press release as Exhi
• Sinovac Biotech Files 6-K Report — Jan 16, 2025 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K report on January 16, 2025, for the month of January 2025. The report is a routine filing for a foreign private issuer and
• Sinovac Biotech Ltd. Files August 2024 6-K Report — Aug 16, 2024 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on August 16, 2024, to report its activities for the month of August 2024. The filing includes a signature by Nan Wang, Ch
• Sinovac Biotech Ltd. Files 6-K Report — Apr 30, 2024 Risk: low
  Sinovac Biotech Ltd. filed a Form 6-K on April 30, 2024, for the month of April 2024. The filing was signed by Nan Wang, Chief Financial Officer, on April 29, 2
• Sinovac Biotech Files Fifth Amendment on Feb 21, 2024 — Feb 21, 2024 Risk: medium
  On February 21, 2024, Sinovac Biotech Ltd. (the "Company") filed a Form 6-K with the SEC, indicating it entered into a fifth amendment. This filing, under Commi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX